Biofrontera Inc. (BFRI) financial statements and ratios from SEC XBRL: revenue $41.70M (TTM), net margin -25.3%, revenue growth 32.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $41.70M |
| Net Margin | -25.3% |
| Revenue Growth (YoY) | 32.9% |
| EPS Growth (YoY) | -91.2% |
| FCF Growth (YoY) | -45.6% |
| Price / Book | 3.68 |
| Price / Sales | 0.47 |
| FCF Yield | -36.2% |
| Altman Z-Score | -5.29 (distress) |
| Sector P/E (Healthcare) | 21.7 |
BFRI overview · BFRI earnings · BFRI KPIs · BFRI investor relations · BFRI ownership · BFRI peers · BFRI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.